Literature DB >> 17709393

Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1.

Sandra Blanco1, Claudio Santos, Pedro A Lazo.   

Abstract

Hypoxia represents a major stress that requires an immediate cellular response in which different signaling pathways participate. Hypoxia induces an increase in the activity of TAK1, an atypical mitogen-activated protein kinase kinase kinase (MAPKKK), which responds to oxidative stress by triggering cascades leading to the activation of c-Jun N-terminal kinase (JNK). JNK activation by hypoxia requires assembly with the JIP1 scaffold protein, which might also interact with other intracellular proteins that are less well known but that might modulate MAPK signaling. We report that TAK1 is able to form a stable complex with JIP1 and thus regulate the activation of JNK, which in turn determines the cellular stress response to hypoxia. This activation of TAK1-JIP1-JNK is suppressed by vaccinia-related kinase 2 (VRK2). VRK2A is able to interact with TAK1 by its C-terminal region, forming stable complexes. The kinase activity of VRK2 is not necessary for this interaction or the downregulation of AP1-dependent transcription. Furthermore, reduction of the endogenous VRK2 level with short hairpin RNA can increase the response induced by hypoxia, suggesting that the intracellular levels of VRK2 can determine the magnitude of this stress response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709393      PMCID: PMC2168905          DOI: 10.1128/MCB.00025-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.

Authors:  K Kishimoto; K Matsumoto; J Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 2.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors.

Authors:  Walter Kolch
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

3.  Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2.

Authors:  Pattama Singhirunnusorn; Shunsuke Suzuki; Noritaka Kawasaki; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

4.  JIP1 regulates neuronal apoptosis in response to stress.

Authors:  Zhaohui Dong; Li Zhou; Keith Del Villar; Mahin Ghanevati; Vartan Tashjian; Carol A Miller
Journal:  Brain Res Mol Brain Res       Date:  2005-04-04

Review 5.  Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.

Authors:  Delphine Javelaud; Alain Mauviel
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

6.  c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.

Authors:  Katrina M Comerford; Eoin P Cummins; Cormac T Taylor
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

7.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Authors:  Jae-Hyuck Shim; Changchun Xiao; Amber E Paschal; Shannon T Bailey; Ping Rao; Matthew S Hayden; Ki-Young Lee; Crystal Bussey; Michael Steckel; Nobuyuki Tanaka; Gen Yamada; Shizuo Akira; Kunihiro Matsumoto; Sankar Ghosh
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

8.  Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors.

Authors:  Andrea Hoffmann; Olena Preobrazhenska; Claas Wodarczyk; Yvonne Medler; Andreas Winkel; Sandra Shahab; Danny Huylebroeck; Gerhard Gross; Kristin Verschueren
Journal:  J Biol Chem       Date:  2005-05-23       Impact factor: 5.157

Review 9.  From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.

Authors:  Michael Karin; Ewen Gallagher
Journal:  IUBMB Life       Date:  2005 Apr-May       Impact factor: 3.885

10.  Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop.

Authors:  Jae J Song; Yong J Lee
Journal:  J Cell Biol       Date:  2005-07-04       Impact factor: 10.539

View more
  36 in total

1.  VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling.

Authors:  Isabel F Fernández; Luis G Pérez-Rivas; Sandra Blanco; Adrián A Castillo-Dominguez; José Lozano; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

2.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

3.  VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.

Authors:  Isabel F Fernández; Sandra Blanco; José Lozano; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

4.  Vaccinia-Related Kinase 2 Controls the Stability of the Eukaryotic Chaperonin TRiC/CCT by Inhibiting the Deubiquitinating Enzyme USP25.

Authors:  Sangjune Kim; Dohyun Lee; Juhyun Lee; Haengjin Song; Hyo-Jin Kim; Kyong-Tai Kim
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

5.  Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Authors:  Annabel T Olson; Amber B Rico; Zhigang Wang; Gustavo Delhon; Matthew S Wiebe
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

6.  Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC.

Authors:  Sangjune Kim; Do-Young Park; Dohyun Lee; Wanil Kim; Young-Hun Jeong; Juhyun Lee; Sung-Kee Chung; Hyunjung Ha; Bo-Hwa Choi; Kyong-Tai Kim
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

7.  TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70.

Authors:  Zhiyu Chen; Xiaolu Shen; Fengyan Shen; Wei Zhong; Hai Wu; Sha Liu; Jiang Lai
Journal:  Mol Cell Biochem       Date:  2013-02-02       Impact factor: 3.396

8.  Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2.

Authors:  Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

9.  Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-β1/TAK1 signaling pathway.

Authors:  Zhi-Ru Ge; Mao-Chun Xu; Y U Huang; Chen-Jun Zhang; J E Lin; Chang-Wu Ruan
Journal:  Exp Ther Med       Date:  2016-04-04       Impact factor: 2.447

10.  Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia.

Authors:  Run-Qiang Chen; Qing-Kai Yang; Yan-Ling Chen; Vasco A Oliveira; William S Dalton; Colleen Fearns; Jiing-Dwan Lee
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.